Halodoc has allowed society to access over 20,000 medical practitioners, 3,300 hospitals, and 4,900 pharmacies since its inception in 2016.
Heaptalk, Jakarta — Indonesia’s digital healthcare platform, Halodoc, has accomplished a new injection in a Series D funding round worth US$100 million, equal to Rp1.5 trillion. Astra International leads this investment round, with participation from Openspace, Novo Holdings, Denmark’s investor. Through this latest round, Astra’s total investment disbursed for this health-tech startup attained US$135 million (around Rp2 trillion).
The startup will allocate the fund to four essential matters, which cover strengthening an integrated ecosystem by involving more health actors, such as doctors, pharmacists, hospitals, clinics, and insurance, developing preventive health services, such as Home Lab service, enhancing My Insurance feature to facilitate users in gaining integrated insurance service, and increasing public awareness of a healthy lifestyle.
The CEO and Co-Founder of Halodoc, Jonathan, delivered, “We would like to thank our partners for their enormous contribution and trust since the early inception of Halodoc. The impact that the company has also created a testament to partners’ commitment to supporting the acceleration of digital adoption in the healthcare sector,”
The Covid-19 pandemic has indirectly encouraged people to use telemedicine services like online medical consultations. Based on data from the Indonesian Telemedicine Alliance (Atensi), around 17.9 million health consulting activities will come from 19 telemedicine companies in 2022, which indicates that digital technology plays a crucial role in Indonesia’s health industry progress.
As delivered by the President Director of Astra International, Djony Buarto Tjondro, he revealed that the high demand for access to quality health services has driven the digital technology adoption in health services. Furthermore, he considered Indonesia’s health sector continues to perform promising growth prospects in the long term, along with the government’s efforts to advance the health sector in the archipelago.
Moreover, based on Statista data, the digital health industry is projected to reach US$3.97 billion in 2027, with a CAGR growth of 15% from a market value of US$1.98 billion in 2022. With this promise, Astra hopes to contribute and take advantage of this potential by continuously improving its digital competence and becoming an organization that adheres to sustainability principles.
Since being established in 2016, Halodoc has allowed Indonesian society to access more than 20,000 medical practitioners, 3,300 hospitals, and 4,900 pharmacies. In 2022, this telemedicine startup will have more than 20 million monthly active users connected to the Halodoc platform.
The startup is also working closely with the government to accelerate technological advancement in the healthcare industry, including through the initiation of telehealth regulation as outlined in the Ministry of Health (MoH) of the Republic of Indonesia. The MoH has implemented the Regulatory Sandbox to facilitate Digital Health Innovation (IDK) organizers such as Halodoc.
Through this Regulatory Sandbox, the Ministry provides a safe space for Halodoc and other IDK organizers to partner with the government in developing sustainable and high-quality innovations while ensuring user safety as a top priority. This health tech startup based in Indonesia has obtained ISO 27001 and ISO 27701 certifications to provide quality service.
Participating in this Series D round, the Partner of Novo Holdings, Navjeewan Khosla, stated, “Halodoc is improving affordability and access to healthcare in Indonesia with its robust digital technology and a wide network of providers and partnerships. The company’s successful track record with national vaccination campaigns and Covid-19 vaccination response, and their ability to serve more than 20 million patients with convenient and high-quality healthcare is a strong foundation for sustainable enhancement,”
